Search

Search Constraints

You searched for: Author/Creator Smith, Ian E.

Search Results

1. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update. Issue 35 (10th December 2021)

3. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. Issue 6 (April 2015)

4. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. (March 2016)

5. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. (March 2016)

9. Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D). (May 2021)